Ten years after the first biosimilar launched on the U.S. market, the FDA is taking steps to make biosimilar development and pharmacy substitution more like that of generics, reducing the cost of the ...

TIOBE Index for October 2025: Top 10 Most Popular Programming Languages Your email has been sent The October TIOBE Programming Community Index brought a few quiet but meaningful shifts. Python remains ...

Sales success doesn’t come from a cookie-cutter approach. While generic training programs offer broad guidance, they often miss the mark when it comes to addressing the specific challenges your team ...

In an analysis comparing college admission essays generated by artificial intelligence to 30,000 human-written essays from before ChatGPT was released, Cornell University researchers found that AI ...

Oct. 3 (UPI) --The Trump administration this week approved a second generic abortion pill despite opposition from Republicans and anti-abortionists. The Food and Drug Administration approved the ...

Federal regulators have approved a second generic version of the abortion pill mifepristone, a routine step that quickly drew backlash from anti-abortion groups and some Republican lawmakers.

The FDA signed off on a second generic option for the abortion pill mifepristone on Tuesday, hours before most of the federal government shut down and despite Republican opposition to the drug. Evita ...

WASHINGTON (AP) — Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups and ...

The decision enraged opponents of abortion, who have been pressuring the Trump administration to restrict access to abortion medication. By Pam Belluck The Food and Drug Administration has approved a ...

US President Donald Trump’s latest tariff order imposing a 100 percent levy on branded or patented pharmaceuticals is unlikely to dent India’s drug exports, which primarily comprises of generics or ...

Sept 23 (Reuters) - Bausch Health (BHC.TO), opens new tab and Teva Pharmaceuticals (TEVA.TA), opens new tab were sued on Monday for allegedly conspiring to delay sales of a generic version of Bausch’s ...